Yuefan Zhang

Yuefan Zhang


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 December 2018 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
YYYongsheng Yu
Yongsheng Yu
YLYu Liu
Yu Liu
WAWeishuai An
Weishuai An
LWLianghua Wang
Lianghua Wang
YZYuefan Zhang
Yuefan Zhang
XZXianxian Zhao
Xianxian Zhao
Innate immune activation contributes to the transition from nonalcoholic fatty liver to nonalcoholic steatohepatitis (NASH). Stimulator of IFN genes (STING, also referred to Tmem173) is a universal receptor that recognizes released DNA and triggers innate immune activation. In this work, we investigated the role of STING in the progression of NASH in mice. Both methionine- and choline-deficient diet (MCD) and high-fat diet (HFD) were used to induce NASH in mice. Strikingly, STING deficiency attenuated steatosis, fibrosis, and inflammation in livers in both murine models of NASH. Additionally, STING deficiency increased fasting glucose levels in mice independently of insulin, but mitigated HFD-induced insulin resistance and weight gain and reduced levels of cholesterol, triglycerides, and LDL in serum; it also enhanced levels of HDL. The mitochondrial DNA (mtDNA) from hepatocytes of HFD-fed mice induced TNF-α and IL-6 expression in cultured Kupffer cells (KCs), which was attenuated by STING deficiency or pretreatment with BAY11-7082 (an NF-κB inhibitor). Finally, chronic exposure to 5,6-dimethylxanthenone-4-acetic acid (DMXAA, a STING agonist) led to hepatic steatosis and inflammation in WT mice, but not in STING-deficient mice. We proposed that STING functions as an mtDNA sensor in the KCs of liver under lipid overload and induces NF-κB–dependent inflammation in NASH.

20 June 2016 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Closed access
PDF file
YLYing Liu
Ying Liu
SJShu Jiang
Shu Jiang
PYPeng‐Yuan Yang
Peng‐Yuan Yang
YZYuefan Zhang
Yuefan Zhang
TLTie‐Jun Li
Tie‐Jun Li
YRYao‐Cheng Rui
Yao‐Cheng Rui

29 May 2024 in Chinese Chemical Letters
Verified
Journal Article
Closed access
SYShudi Yu
Shudi Yu
JLJie Li
Jie Li
JYJiongting Yin
Jiongting Yin
WLWanyu Liang
Wanyu Liang
YZYangping Zhang
Yangping Zhang
YDYukou Du
Yukou Du

26 February 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
QZQiuzhen Zhu
Qiuzhen Zhu
YZYuefan Zhang
Yuefan Zhang
YLYulan Liu
Yulan Liu
HCHao Cheng
Hao Cheng
JWJing Wang
Jing Wang
TLTiejun Li
Tiejun Li
Monocyte locomotion inhibitory factor (MLIF), a heat-stable pentapeptide, has been shown to exert potent anti-inflammatory effects in ischemic brain injury. In this study, we investigated the neuroprotective action of MLIF against oxygen-glucose deprivation (OGD)-induced injury in human neuroblastoma SH-SY5Y cells. MTT assay was used to assess cell viability, and flow cytometry assay and Hoechst staining were used to evaluate apoptosis. LDH assay was used to exam necrosis. The release of inflammatory cytokines was detected by ELISA. Levels of the apoptosis associated proteins were measured by western blot analysis. To identify the protein target of MLIF, pull-down assay and mass spectrometry were performed. We observed that MLIF enhanced cell survival and inhibited apoptosis and necrosis by inhibiting p-JNK, p53, c-caspase9 and c-caspase3 expression. In the microglia, OGD-induced secretion of inflammatory cytokines was markedly reduced in the presence of MLIF. Furthermore, we found that eukaryotic translation elongation factor 1A2 (eEF1A2) is a downstream target of MLIF. Knockdown eEF1A2 using short interfering RNA (siRNA) almost completely abrogated the anti-apoptotic effect of MLIF in SH-SY5Y cells subjected to OGD, with an associated decrease in cell survival and an increase in expression of p-JNK and p53. These results indicate that MLIF ameliorates OGD-induced SH-SY5Y neuroblastoma injury by inhibiting the p-JNK/p53 apoptotic signaling pathway via eEF1A2. Our findings suggest that eEF1A2 may be a new therapeutic target for ischemic brain injury.

17 May 2019 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
HZHui Zhao
Hui Zhao
JMJunqin Mao
Junqin Mao
YYYuan Yuan
Yuan Yuan
JFJingjing Feng
Jingjing Feng
HCHao Cheng
Hao Cheng
TLTiejun Li
Tiejun Li
Sodium dichloroacetate (DCA) is a mitochondrial pyruvate dehydrogenase kinase inhibitor, and has been shown to display vasoprotective effects in chronic ischemic stroke. The purpose of this study was to evaluate the therapeutic effect of DCA on vascular dementia (VD) and endothelial progenitor cell (EPC)-mediated angiogenesis. After cerebral ischemia-reperfusion in rats, DCA was administered continuously for 21 days; following which, histological analysis, and cognitive functional tests were conducted. Rat bone marrow-derived EPCs were isolated, their function and quantity were measured, and the effects of long-term administration of DCA on EPCs in a rat model of VD was studied. We found that long-term DCA administration improved cognitive function in VD rats, reduced brain infarct size and brain atrophy, increased VEGF and bFGF levels in vivo, promoted angiogenesis in damaged areas, and significantly improved EPC function in VD rats. Compared with the VD group, AKT, Nrf2, eNOS expression, and intracellular NO levels were elevated in EPCs of DCA-treated VD rats. In addition, GSK3β and intracellular ROS levels were decreased. Simultaneously, it was found that DCA directly acted on EPCs, and improved EPC functional behavior. Taken together, these findings suggested that long-term DCA administration improved cognitive function in a rat model of VD, and did so in part, by improving EPC function. Observations suggest that prolonged DCA administration might be beneficial in treating VD.

1 September 2016 in Environmental Toxicology and Pharmacology
Verified
Journal Article
Closed access
JWJing Wang
Jing Wang
YZYue Zhang
Yue Zhang
QZQiuzhen Zhu
Qiuzhen Zhu
YLYulan Liu
Yulan Liu
HCHao Cheng
Hao Cheng
TLTiejun Li
Tiejun Li